{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T04:41:22Z","timestamp":1792384882398,"version":"4.4.0"},"reference-count":45,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dom-pubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To further characterise the effects of retatrutide on cardiometabolic risk, lipoprotein and inflammatory biomarkers were assessed post hoc in phase 2 trials of adults with obesity\/overweight with or without type 2 diabetes (T2D).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>\n                      Data were analysed from two randomised, double\u2010blind, placebo\u2010controlled phase 2 trials. In Study 1, adults with obesity\/overweight and T2D received once\u2010weekly retatrutide (0.5\/4\/8\/12\u2009mg), dulaglutide (1.5\u2009mg) or placebo for 36\u2009weeks; in Study 2, adults with clinical obesity without T2D received retatrutide (1\/4\/8\/12\u2009mg) or placebo for 48\u2009weeks. Fasting blood samples were collected at baseline and during treatment to assess lipids, apolipoproteins, lipoprotein particle subclasses and inflammatory biomarkers. Mixed models for repeated measures estimated placebo\u2010adjusted change from baseline. Statistical significance was defined as a false discovery rate\u2010adjusted\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Mean body mass index was 35.4\u2009kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      (Study 1) and 37.4\u2009kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      (Study 2). In both studies, retatrutide was associated with significant reductions in non\u2010high\u2010density lipoprotein cholesterol (Study 1: up to \u221221.0%, Study 2: up to \u221226.9%), apolipoprotein B (\u221221.4%, \u221224.2%), total triglyceride\u2010rich lipoprotein particles (\u221222.5%, \u221233.7%), large triglyceride\u2010rich lipoprotein particles (\u221284.4%, \u221276.6%), triglyceride\u2010rich lipoprotein cholesterol (\u221229.4%, \u221238.6%), total low\u2010density lipoprotein particles (\u221219.7%, \u221223.5%) and small low\u2010density lipoprotein particles (\u221232.6%, \u221232.3%). Retatrutide was associated with significant reductions in high\u2010sensitivity C\u2010reactive protein (\u221254.8%) and interleukin\u20106 (\u221229.6%) in Study 2 but not Study 1.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In adults with obesity\/overweight, with or without T2D, retatrutide treatment was associated with reductions in atherogenic lipoproteins and inflammatory biomarkers linked to cardiovascular disease risk.<\/jats:p>\n                    <jats:p>\n                      <jats:bold>Trial Registration:<\/jats:bold>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/clinicaltrials.gov\">ClinicalTrials.gov<\/jats:ext-link>\n                      numbers NCT04881760 and NCT04867785\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/dom.71200","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:55:10Z","timestamp":1787018110000},"page":"10183-10194","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Retatrutide\u2010Associated Improvements in Cardiovascular Risk Biomarkers in Adults With Obesity With or Without Type 2 Diabetes"],"prefix":"10.1111","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5247-5444","authenticated-orcid":false,"given":"Giacomo","family":"Ruotolo","sequence":"first","affiliation":[{"name":"Eli Lilly &amp; Company  Indianapolis Indiana USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Harris","sequence":"additional","affiliation":[{"name":"Eli Lilly &amp; Company  Indianapolis Indiana USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhu","family":"Lin","sequence":"additional","affiliation":[{"name":"Eli Lilly &amp; Company  Indianapolis Indiana USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Wilson","sequence":"additional","affiliation":[{"name":"Eli Lilly &amp; Company  Indianapolis Indiana USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Pirro","sequence":"additional","affiliation":[{"name":"Eli Lilly &amp; Company  Indianapolis Indiana USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin L.","family":"Duffin","sequence":"additional","affiliation":[{"name":"Eli Lilly &amp; Company  Indianapolis Indiana USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9848-2834","authenticated-orcid":false,"given":"Melissa K.","family":"Thomas","sequence":"additional","affiliation":[{"name":"Eli Lilly &amp; Company  Indianapolis Indiana USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark L.","family":"Hartman","sequence":"additional","affiliation":[{"name":"Eli Lilly &amp; Company  Indianapolis Indiana USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciara O'","family":"Neill","sequence":"additional","affiliation":[{"name":"Eli Lilly &amp; Company  Indianapolis Indiana USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2481-133X","authenticated-orcid":false,"given":"Tamer","family":"Coskun","sequence":"additional","affiliation":[{"name":"Eli Lilly &amp; Company  Indianapolis Indiana USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zvonko","family":"Milicevic","sequence":"additional","affiliation":[{"name":"Eli Lilly &amp; Company  Indianapolis Indiana USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4502-0470","authenticated-orcid":false,"given":"Axel","family":"Haupt","sequence":"additional","affiliation":[{"name":"Eli Lilly &amp; Company  Indianapolis Indiana USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1604-2593","authenticated-orcid":false,"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[{"name":"School of Cardiovascular and Metabolic Health University of Glasgow  Glasgow UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Nicholls","sequence":"additional","affiliation":[{"name":"Victorian Heart Institute Monash University  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/eci.70151"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.12.013"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2021.06.005"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)02403-5"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)01375-3"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101737"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.7326\/ANNALS-24-02623"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14553"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14174"},{"key":"e_1_2_11_11_1","unstructured":"S.Nicholls \u201cThe Cardiovascular Outcomes in Participants on Tirzepatide Versus Dulaglutide of the SURPASS\u2010CVOT \u201dpresented at the 61st European Association for the Study of Diabetes (EASD) Annual Meeting; September 15\u201319 (2025)."},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.70040"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(23)00356-X"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.00413"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03018-2"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2301972"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01053-X"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cll.2006.07.006"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2011.02.001"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2517-6161.1995.tb02031.x"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2021.0929"},{"issue":"5","key":"e_1_2_11_22_1","first-page":"1362","article-title":"Effect of Semaglutide on Subclinical Atherosclerosis and Cardiometabolic Compensation: A Real\u2010World Study in Patients With Type 2 Diabetes","volume":"11","author":"Patti A. M.","year":"2023","journal-title":"Biomedicine"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26135951"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.P600011-JLR200"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200419992"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI30163"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13679-025-00623-1"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2019.09.010"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI146353"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa863"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.16661"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M075689"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.120.315204"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02494-2"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0000000000000910"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2507227"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2404143"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2031049"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)00507-0"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125935"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-010-1831-8"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-013-3145-0"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1508"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61350-5"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx144"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)02105-1"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dom.71200","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dom.71200","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dom.71200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T04:19:30Z","timestamp":1792383570000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/10.1111\/dom.71200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10.1111\/dom.71200"],"URL":"https:\/\/doi.org\/10.1111\/dom.71200","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.1111\/DOM.71200\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.71200\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.71200\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.71200\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.71200\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.71200\/v1\/review2","asserted-by":"object"}]},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"value":"1462-8902","type":"print"},{"value":"1463-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"assertion":[{"value":"2026-05-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}